AI assistant
CSL Ltd. — Board/Management Information 2024
Aug 12, 2024
17854_rns_2024-08-12_bc332edd-181f-46d1-8b1c-e112dd558b87.pdf
Board/Management Information
Open in viewerOpens in your device viewer
For immediate release
13 August 2024
==> picture [596 x 198] intentionally omitted <==
APPOINTMENT OF NEW NON-EXECUTIVE DIRECTOR
Melbourne, Australia – CSL (ASX:CSL; USOTC:CSLLY)
CSL Limited (ASX:CSL; USOTC:CSLLY) today announces the appointment of Ms Elaine Sorg as an independent Non-executive Director, effective 1 September 2024.
CSL’s Chair, Dr Brian McNamee AO said “We are pleased to welcome Elaine to CSL’s Board of Directors. She is a well-respected global leader in the biopharmaceutical industry, with a track record of successfully building franchises and brands across therapeutic areas and segments.
“Her expertise will be a strong complement to our Boards existing skillset, and be vital as CSL continues to execute on its growth ambitions.”
Ms Sorg has more than 35 years’ experience as a senior executive with leading pharmaceutical companies including AbbVie and Eli Lilly. Prior to her retirement in 2023, Ms Sorg was Senior Vice President for AbbVie and President of AbbVie’s US commercial operations, the company’s largest commercial business. She was a key leader in bringing a number of groundbreaking medicines to patients across Immunology, Oncology, Neuroscience and Eye Care.
Ms Sorg holds a Bachelor of Science (Pharmacy) from Purdue University, as well as postgraduate certifications from the University of Chicago Booth School of Management, and Harvard Business School. She is currently on the Dean’s Advisory Council at Purdue University School of Pharmacy and Pharmaceutical Science, and is a Senior Advisor at the Boston Consulting Group, where she advises global health care clients on business-critical strategies and decisions.
Authorised for lodgment by:
==> picture [97 x 45] intentionally omitted <==
Fiona Mead Company Secretary
For further information, please contact:
Media:
Investors: Media: Chris Cooper Bernard Ronchi Stephen McKeon Jimmy Baker Head, Investor Relations Director, Investor Relations Director, Investor Relations Communications CSL Limited CSL Limited CSL Limited CSL Limited P: +61 455 022 740 P: +61 3 9389 3470 P: 61 402 231 696 P: +61 450 909 211 E: [email protected] E: [email protected] E: [email protected] E: [email protected]